The vexing problem of thrombosis in long-term mechanical circulatory support

Journal of Heart and Lung Transplantation

Volumn 33, Issue 1, 2014, Pages 1-11

  Mehra, Mandeep R ^a   Stewart, Garrick C ^a   Uber, Patricia A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

Heartmate II; HeartWare; Left ventricular assist device; Thrombosis

Indexed keywords

EPTIFIBATIDE;

BLEEDING; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEVICE INFECTION; FLOW KINETICS; FUNCTIONAL STATUS; HEART FAILURE; HEMOLYSIS; HUMAN; INCIDENCE; LEFT VENTRICULAR ASSIST DEVICE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; THROMBOSIS;

HEARTMATE II; HEARTWARE; LEFT VENTRICULAR ASSIST DEVICE; THROMBOSIS;

ANTICOAGULANTS; EQUIPMENT FAILURE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; PLATELET AGGREGATION INHIBITORS; PREVALENCE; THROMBOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84892158176     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.12.002     Document Type: Editorial

References (61)

1. L.W. Miller, F.D. Pagani, and S.D. Russell et al. Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
2. M.S. Slaughter, J.G. Rogers, and C.A. Milano et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
3. K.D. Aaronson, M.S. Slaughter, and L.W. Miller et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
4. J.G. Rogers, K.D. Aaronson, and A.J. Boyle et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients J Am Coll Cardiol 55 2010 1826 1834
5. A.L. Meyer, D. Malehsa, and C. Bara et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circulation 3 2010 675 681
6. J.A. Morgan, G. Paone, and H.W. Nemeh et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device J Heart Lung Transplant 31 2012 715 718
7. J. Cowger, F.D. Pagani, J.W. Haft, M.A. Romano, K.D. Aaronson, and T.J. Kolias The development of aortic insufficiency in left ventricular assist device-supported patients Circ Heart Failure 3 2010 668 674
8. R. John, K. Mantz, P. Eckman, A. Rose, and K. May-Newman Aortic valve pathophysiology during left ventricular assist device support J Heart Lung Transplant 29 2010 1321 1329
9. D. Feldman, S.V. Pamboukian, and J.J. Teuteberg et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary J Heart Lung Transplant 32 2013 157 187
10. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
11. F.D. Pagani, L.W. Miller, and S.D. Russell et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
12. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients J Heart Lung Transplant 32 2013 141 156
13. R.C. Starling, Y. Naka, and A.J. Boyle et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
14. S.V. Pamboukian, J.A. Tallaj, and R.N. Brown et al. Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol J Heart Lung Transplant 30 2012 879 887
15. S.J. Park, C.A. Milano, and A.J. Tatooles et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy Circ Heart Failure 5 2012 241 248
16. J.K. Kirklin, D.C. Naftel, and R.L. Kormos et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 33 2014 12 22
17. R.C. Starling, N. Moazami, and S.C. Silvestry et al. Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
18. L.W. Stevenson The urgent priority for transplantation is to trim the waiting list J Heart Lung Transplant 32 2013 861 867
19. S.S. Najjar, M.S. Slaughter, and F.D. Pagani et al. An analysis of pump thrombosis events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol J Heart Lung Transplant 33 2014 23 34
20. M.S. Slaughter, F.D. Pagani, and E.C. McGee et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
21. J.J. Teutenberg, G.C. Stewart, and M. Jessup et al. Implant strategies change over time and impact outcomes JACC Heart Fail 1 2013 369 378
22. M.S. Slaughter, Y. Naka, and R. John et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy J Heart Lung Transplant 29 2010 616 624
23. A.J. Boyle, S.D. Russell, and J.J. Teuteberg et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation J Heart Lung Transplant 28 2009 881 887
24. O. Wever-Pinzon, C.H. Selzman, and S.G. Drakos et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II Circ Heart Failure 6 2013 517 526
25. J.M. Stulak, D. Lee, and J.W. Haft et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device J Heart Lung Transplant 33 2014 60 64
26. O. Saeed, S. Maybaum, D. D'Alessandro, D.J. Goldstein, and S.R. Patel Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices J Heart Lung Transplant 33 2014 109 111
27. U.S. Food and Drug Administration. Thoratec Corporation issues worldwide medical device correction of HeartMate II® Left Ventricular Assist System. Available from: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ucm112525. htm. Accessed December 4, 2013.
28. U.S. Food and Drug Administration. Thoratec Corporation, HeartMate II Left Ventricular Assist System (LVAS): class 1 recall- outflow graft may kink or deform. Available from: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm298710.htm. Accessed December 4, 2013.
29. N. Uriel, J. Han, and K.A. Morrison et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon J Heart Lung Transplant 33 2014 51 59
30. C. Salerno, K.S. Sundareswaran, T.P. Schleeter, S.L. Moanie, D.J. Farrar, and M.N. Walsh Early elevation in pump power with the HeartMate II left ventricular assist device does not predict late adverse events J Heart Lung Transplant 32 2013 S38 S39
31. S. Taghavi, C. Ward, S.N. Jayarajan, J. Gaughan, L.M. Wilson, and A.A. Mangi Surgical technique influences HeartMate II left ventricular assist device thrombosis Ann Thorac Surg 96 2013 1259 1265
32. A.Y. Chong, and G.Y. Lip Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response? Eur J Heart Fail 9 2007 124 128
33. M. Gheorghiade, A. Thyssen, and R. Zolynas et al. Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure J Heart Lung Transplant 30 2011 218 226
34. B.H. Freed, V. Jeevanandam, and N. Jolly Aortic root and valve thrombosis after implantation of a left ventricular assist device J Invasive Cardiol 23 2011 E63 E65
35. J. Fried, J. Han, Y. Naka, U. Jorde, and N. Uriel Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombosis, and outcomes J Heart Lung Transplant 33 2014 112 115
36. Z.T. Demirozu, and O.H. Frazier Aortic valve noncoronary cusp thrombosis after implantation of a nonpulsatile, continuous-flow pump Tex Heart Inst J 39 2012 618 620
37. J.T. Reul, G.J. Reul, and O.H. Frazier Carotid-bulb thrombus and continuous-flow left ventricular assist devices: a novel observation J Heart Lung Transplant 33 2014 107 108
38. M.R. Shah, D.C. Naftel, and M.A. Miller et al. Thrombotic complications increase after percutaneous site/pocket infection in patients with left ventricular assist devices: an INTERMACS analysis J Heart Lung Transplant 32 2013 S84 S85
39. N. Uriel, K.A. Morrison, and A.R. Garan et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study J Am Coll Cardiol 60 2012 1764 1775
40. P. Shah, V.M. Mehta, J.A. Cowger, K.D. Aaronson, and F.D. Pagani Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support J Heart Lung Transplant 33 2014 102 104
41. A.K. Ravichandran, J. Parker, and E. Novak et al. Hemolysis in left ventricular assist devices: A retrospective analysis of outcomes J Heart Lung Transplant 33 2014 44 50
42. J.A. Cowger, M.A. Romano, and P. Shah et al. Hemolysis: A harbinger of adverse outcome after left ventricular assist device implant J Heart Lung Transplant 33 2014 35 43
43. H. Alhosaini, B.C. Jensen, P.P. Chang, B.C. Sheridan, and J.N. Katz A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices J Heart Lung Transplant 33 2014 116 117
44. R.J. Steffen, E.G. Soltesz, K. Miracle, S. Lee, M.M. Mountis, and N. Moazami Incidence of increases in pump power use and associated clinical outcomes with an axial continuous-flow ventricular assist device J Heart Lung Transplant 33 2014 105 106
45. M.D. Thomas, C. Wood, M. Lovett, L. Dembo, and G. O'Driscoll Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban J Heart Lung Transplant 27 2008 925 927
46. A.H. Al-Quthami, M. Jumean, and R. Kociol et al. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis Circ Heart Failure 5 2012 e68 e70
47. B.R. Tellor, J.R. Smith, S.M. Prasad, S.M. Joseph, and S.C. Silvestry The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices J Heart Lung Transplant 33 2014 94 101
48. T. Ota, H. Yerebakan, and H. Akashi et al. Continuous-flow left ventricular assist device exchange: Clinical outcomes J Heart Lung Transplant 33 2014 65 70
49. N. Moazami, C.A. Milano, and R. John et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality Ann Thorac Surg 95 2013 500 505
50. D.J. Goldstein, R. John, and C. Salerno et al. Algorithm for the diagnosis and management of suspected pump thrombus J Heart Lung Transplant 32 2013 667 670
51. S.E. Sandner, J. Riebandt, and T. Haberl et al. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation J Heart Lung Transplant 33 2014 88 93
52. R.M. Gellatly, A. Lett, and K.E. Brown Fondaparinux: An effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support J Heart Lung Transplant 33 2014 118
53. J.W. Eikelboom, S.J. Connolly, and M. Brueckmann et al. Dabigatran versus warfarin in patients with mechanical heart valves N Engl J Med 369 2013 1206 1214
54. M. Goda, S. Jacobs, and F. Rega et al. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump J Heart Lung Transplant 32 2013 539 545
55. J. Suarez, C.B. Patel, G.M. Felker, R. Becker, A.F. Hernandez, and J.G. Rogers Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices Circ Heart Failure 4 2011 779 784
56. N. Uriel, S.W. Pak, and U.P. Jorde et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
57. J. Hu, N.K. Mondal, and E.N. Sorensen et al. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices J Heart Lung Transplant 33 2014 71 79
58. I. Brischmann, M. Dittrich, and T. Eller et al. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare LVADs J Heart Lung Transplant 2014 (In press this issue)
59. N. Moazami, K. Fukamachi, and M. Kobayashi et al. Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice J Heart Lung Transplant 32 2013 1 11
60. J.K. Kirklin, and M.R. Mehra The dawn of the ISHLT Mechanical Assisted Circulatory Support (IMACS) Registry: fulfilling our mission J Heart Lung Transplant 31 2012 115 116
61. J.T. Baldwin, and D.L. Mann NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial J Card Failure 16 2010 855 858